PMID: 2091812Jan 1, 1990Paper

A girl treated with growth hormone presenting with neuromyopathy as first sign of acute lymphoblastic leukemia

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
T J de GrauwF C de Waal

Abstract

An 11-year-old girl being treated with DNA-recombinant growth hormone therapy presented with proximal limb weakness. Laboratory studies were negative. A few months later she presented with acute lymphoblastic leukemia (ALL). A diagnosis of carcinomatous neuromyopathy was made. After successful treatment of the leukemia the symptoms subsided and did not recur.

References

Mar 1, 1979·Annals of Neurology·S C ScholdJ B Posner
Sep 1, 1978·Annals of Neurology·S A Barron, R R Heffner
May 1, 1987·Neuropediatrics·M C Dalakas, W K Engel
Sep 19, 1985·The New England Journal of Medicine·P BrownD M Asher
Apr 1, 1974·Archives of Neurology·M Swash

❮ Previous
Next ❯

Citations

Apr 15, 2008·Trends in Endocrinology and Metabolism : TEM·P Jenkins
Apr 1, 1995·Acta Paediatrica Japonica; Overseas Edition·S InadaM Eguchi
Jun 29, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wing LeungChing-Hon Pui
Feb 27, 2010·British Dental Journal·C Scully

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.